96708 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
COMPOUNDS AND METHODS FOR TREATING DISEASES CAUSED BY VIRUSES AND BACTERIA
#2PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#3NOVEL PROCESSES FOR PREPARING CAMPTOTHECIN DERIVATIVES
#4PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#5INHIBITORS OF NF KAPPA-B ACTIVITY FOR TREATMENT OF DISEASES AND DISORDERS
#6TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#7FAP-ACTIVATED PROTEASOME INHIBITORS FOR TREATING SOLID TUMORS
#8NOD1 MODULATORS AND USES THEREOF
#9RILUZOLE PRODRUGS AND THEIR USE
#10TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS
#11AFFINITY ILLUDOFULVENE CONJUGATES
#12FORMULATION OF MODIFIED INTERLEUKIN-7 FUSION PROTEIN
#13Anti-Inflammatory Compound and Use Thereof
#14THERAPEUTIC AGENTS FOR TREATMENT OF CORONAVIRUS INFECTION
#15PSMA-TARGETED NIR DYES AND THEIR USES
#16HEXAPEPTIDE DERIVATIVE AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND USE THEREOF
#17COSMETIC PEPTIDES FOR IMPROVING SKIN REJUVENATION
#18MULTIVALENT PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME
#19TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#20PEPTIDE, CELL GROWTH PROMOTER, PROTEIN PRODUCTION PROMOTER, CULTURE MEDIUM, CELL GROWTH METHOD USING PEPTIDE, AND PROTEIN PRODUCTION METHOD USING PEPTIDE
#21PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#22INHIBITORS OF NF KAPPA-B ACTIVITY FOR TREATMENT OF DISEASES AND DISORDERS
#23TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS
#24METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID
#25SYNTHETIC PEPTIDE AND APPLICATION THEREOF
#26METHOD FOR PRODUCING GAMMA-GLUTAMYL-VALYL-GLYCINE
#27RILUZOLE PRODRUGS AND THEIR USE
#28Riluzole prodrugs and their use
#29Bioactive Collagen Peptides, Method Of Production Thereof, And Use Thereof
#30PEPTIDE DERIVATIVE WITH COLLAGENASE INHIBITORY ACTIVITY, AND USE THEREOF
#31FORMULATION OF MODIFIED INTERLEUKIN-7 FUSION PROTEIN
#32Affinity illudofulvene conjugates
#33Riluzole prodrugs and their use
#34Peptide macrocycles against
#35LABYRINTHIN-BASED PEPTIDES FOR CANCER IMMUNOTHERAPIES AND USES THEREOF
#36Prodrugs of riluzole and their method of use
#37Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
#38THIOSTREPTON ANALOGS AND METHODS OF MAKING AND USING SAME
#39METHOD OF ENHANCING A BRAIN OR COGNITIVE FUNCTION
#40Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
#41PEPTIDE ACETALS FOR STABILISING ENZYMES
#42BIVALENT ANTAGONISTS OF INHIBITORS OF APOPTOSIS PROTEINS
#43Inhibitors of IAP
#44Piezoelectric peptide-based materials and piezoelectric devices containing same
#45DMSO-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND USE THEREOF
#46Inhibitors for proliferating cell nuclear antigen and uses
#47Inhibitor of apoptosis protein (IAP) antagonists
#48Inhibitors of NF kappa-B activity for treatment of diseases and disorders
#49PSMA-TARGETED NIR DYES AND THEIR USES
#50Peptide for skin aging prevention and wrinkle reduction, and composition comprising same
#51High penetration drugs and their compositions thereof for treatment of Parkinson diseases
#52GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES
#53PEPTIDE INHIBITORS OF TIGHT JUNCTION PERMEABILITY
#54METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID
#55FAP-activated proteasome inhibitors for treating solid tumors
#56DIMERIC PEPTIDE INHIBITORS OF APOPTOSIS PROTEINS
#57Peptoid-peptide macrocycles, pharmaceutical compositions and methods of using the same
#58Riluzole prodrugs and their use
#59PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#60Riluzole prodrugs and their use
#61BIOLOGICALLY ACTIVE C-TERMINAL ARGININE-CONTAINING PEPTIDES
#62Affinity illudofulvene conjugates
#63Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
#64Assay for High-Throughput Identification of Therapeutic Compounds
#65PSMA-targeted NIR dyes and their uses
#66PEPTIDE COMPOSITIONS AND RELATED METHODS
#67Complex, Preparation Methods and Application Thereof
#68PEPTIDE COMPOSITIONS AND RELATED METHODS
#69Proteasome inhibitors
#70FAP-activated proteasome inhibitors for treating solid tumors
#71Inhibitor of apoptosis protein (IAP) antagonists
#72Riluzole prodrugs and their use
#73Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#74Pro-pigmenting peptides
#75Peptide inhibitors of tight junction permeability
#76Tripeptide epoxy ketone protease inhibitors
#77Cross-linkers and their uses
#78Preparation and use of molecular site targeted and activated kinase inhibitor
#79Epoxyketone compounds for enzyme inhibition
#80Riluzole prodrugs and their use
#81ANTIFIBRINOLYTIC COMPOUNDS
#82Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#83Peptoid affinity ligands
#84Peptide macrocycles against
#85GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES
#86Inhibitors of IAP
#87Method of enhancing a brain or cognitive function
#88PSMA-targeted NIR dyes and their uses
#89Pro-pigmenting peptides
#90Inhibitor of apoptosis protein (IAP) antagonists
#91Method for preparing S-Bz-MAG3 as a precursor of contrast media
#92Peptoid affinity ligands
#93PEPTIDE COMPOSITIONS AND RELATED METHODS
#94FAP-activated proteasome inhibitors for treating solid tumors
#95D-ALA-D-ALA-BASED DIPEPTIDES AS TOOLS FOR IMAGING PEPTIDOGLYCAN BIOSYNTHESIS
#96Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
#97Difluoroketamide derivatives as HtrA1 inhibitors
#98Peptide macrocycles against Acinetobacter baumannii
#99Inhibitors for proliferating cell nuclear antigen and uses
#100Skin treatment devices and methods with pre-stressed configurations
#101Formulation of modified interleukin-7 fusion protein
#102Multivalent peptoid oligomers, pharmaceutical compositions and methods of using same
#103Inhibitors of NF κ-B activity for treatment of diseases and disorders
#104Cross-linkers and their uses
#105Compound with effects of thrombolysis, free radical scavenging and thrombus-targeting
#106Methods for assaying palmitoyl protein thioesterase 1 and tripeptidyl peptidase activity in dried blood spots for detection of neuronal ceroid lipofuscinoses in newborns
#107Compounds and methods for enhancing viral gene transfer to human hematopoietic cells
#108Microorganism and method for producing gamma-glutamyl-valyl-glycine
#109Selective cysteine protease inhibitors and uses thereof
#110Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
#111Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
#112Prodrugs of peptide epoxy ketone protease inhibitors
#113Inhibition of gliadin peptides
#114NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#115Organ preservation composition
#116Dispersion and method for forming hydrogel
#117SFRP5-derived peptide fragment and cosmetic composition for skin whitening containing same
#118High penetration drugs and their compositions thereof for treatment of Parkinson diseases
#119Antifibrinolytic compounds
#120BIOLOGICALLY ACTIVE C-TERMINAL ARGININE-CONTAINING PEPTIDES
#121PSMA—targeted NIR dyes and their uses
#122PSMA-targeted NIR dyes and their uses
#123Assay for high-throughput identification of therapeutic compounds
#124Tripeptide compound, preparation method therefor, and application thereof
#125Compounds for enzyme inhibition
#126ABIETANE-TYPE DITERPENOIDS
#127ALDEHYDE CAPTURE LIGATION TECHNOLOGY FOR SYNTHESIS OF AMIDE BONDS
#128Peptide macrocycles against acinetobacter baumannii
#129Epoxyketone compounds for enzyme inhibition
#130CROSS-LINKERS AND THEIR USES
#131HCV PROTEASE INHIBITORS AND USES THEREOF
#132Agonists of neurotrophin receptors and their use as medicaments
#133Cleavage and exchange of major histocompatibility complex ligands employing azobenzene-containing peptides
#134INHIBITION OF GLIADIN PEPTIDES
#135Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#136Biologically active C-terminal arginine-containing peptides
#137Inhibitor of apoptosis protein (IAP) antagonists
#138Sfrp5-derived peptide fragment and cosmetic composition for skin whitening containing same
#139PAR-1 based therapeutic conjugates and uses thereof
#140Pro-pigmenting peptides
#141PSMA-targeted NIR dyes and their uses
#142PSMA-targeted NIR dyes and their uses
#143Inhibitors of NF κ-B activity for treatment of diseases and disorders
#144Myoblast differentiation promoter
#145Hybrid polymers, pharmaceutical compositions and methods of synthesizing the same
#146IAP antagonists
#147Tripeptide epoxy ketone protease inhibitors
#148FAP-activated proteasome inhibitors for treating solid tumors
#149Pharmaceutical compositions containing peptides derived from human BPLP protein
#150Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers
#151Photolabile linker for the solid-phase synthesis of hydrazides and pyranopyrazoles
#152Prodrugs of peptide epoxy ketone protease inhibitors
#153HCV protease inhibitors and uses thereof
#154NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#155D-ALA-D-ALA-BASED DIPEPTIDES AS TOOLS FOR IMAGING PEPTIDOGLYCAN BIOSYNTHESIS
#156Skin treatment devices and methods with pre-stressed configurations
#157Compounds useful as immunomodulators
#158Composite Carrier for Immobilization of Proteins, Polypeptides or Oligopeptides, Preparation Methods and Application Thereof
#159Dispersion and method for forming hydrogel
#160Inhibitors of IAP
#161Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions
#162Liquid automatic dish washing detergent compositions
#163Dipeptide and tripeptide epoxy ketone protease inhibitors
#164Tunable control of protein degradation in synthetic and endogenous bacterial systems
#165PEPTIDE MOLECULAR MATERIALS
#166High penetration drugs and their compositions thereof for treatment of parkinson diseases
#167Amphiphilic linear peptide/peptoid and hydrogel comprising the same
#168Compounds for enzyme inhibition
#169Cross-linkers and their uses
#170IAP antagonists
#171Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#172MYOBLAST DIFFERENTIATION PROMOTER
#173Dual-action, unnatural proline-rich peptides as antibiotic agents and methods thereof
#174NOVEL CHONDRAMIDE DERIVATIVES
#175Pro-pigmenting peptides
#176Enzymes for transforming ergopeptines and method therefor
#177HCV NS3 protease inhibitors
#178IAP antagonists
#179Aldehyde capture ligation technology for synthesis of amide bonds
#180IAP antagonists
#181Azaheterocycles as BIR2 and/or BIR3 inhibitors
#182INHIBITION OF GLIADIN PEPTIDES
#183HCV protease inhibitors and uses thereof
#184Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
#185IAP antagonists
#186Preparation of Technetium-99M Tricarbonyl Labeled Glycine Monomer or Oligomer Containing Probes That Have Biomolecules and Its Application as Imaging Complex-Composition
#187MULTIVALENT PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME
#188Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers
#189Hybrid polymers, pharmaceutical compositions and methods of synthesizing the same
#190Modulators of protease activated receptors
#191Niacin-peptide having skin whitening activity and use for same
#192Agonists of neurotrophin receptors and their use as medicaments
#193Methods for treating pain by administering peptides derived from human basic proline-rich lacrimal protein
#194MBTH-LIKE PROTEINS IN THE PRODUCTION OF SEMI SYNTHETIC ANTIBIOTICS
#195IAP BIR domain binding compounds
#196Tripeptide epoxy ketone protease inhibitors
#197HCV protease inhibitors and uses thereof
#198Synthesis of libraries of peptide tertiary amides
#199DPP-4 inhibitor
#200Method of producing peptide
#201FAP-activated proteasome inhibitors for treating solid tumors
#202Nanoparticle peptide compositions
#203Inhibitors of IAP
#204Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#205Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
#206Cross-linkers and their uses
#207Peptide compositions and methods for treating patients
#208AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS
#209COMPOUNDS FOR ENZYME INHIBITION
#210Prodrugs of peptide epoxy ketone protease inhibitors
#211Prodrugs of peptide epoxy ketone protease inhibitors
#212Methods for assaying enzyme activities
#213Hydrogel-forming material
#214Method for producing peptide
#215Compounds for enzyme inhibition
#216Compounds for enzyme inhibition
#217Selective cysteine protease inhibitors and uses thereof
#218Compounds for enzyme inhibition
#219Peptide-phospholipid conjugates
#220Dimeric Smac Mimetics
#221HCV protease inhibitors and uses thereof
#222Therapeutic or preventive agent for diabetes
#223CHEMICAL LIGATION BY RING OPENING OF OXO-THIOMORPHOLINES
#224Skin treatment devices and methods with pre-stressed configurations
#225Modulations of protease activated receptors
#226Quinoline or quinazoline derivatives with apoptosis inducing activity on cells
#227Drug inhibiting the progression of atherosclerosis, preventive drug, blood cholesterol-lowering drug, functional food, and specific health food
#228IAP BIR domain binding compounds
#229Crystalline peptide epoxyketone immunoproteasome inhibitor
#230Compounds for enzyme inhibition
#231Compounds for enzyme inhibition
#232Compounds for enzyme inhibition
#233Amphiphilic linear peptide/peptoid and hydrogel comprising the same
#234Metal Abstraction Peptide and Uses Thereof
#235HCV protease inhibitors and uses thereof
#236Cross-linkers and their uses
#237Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use
#238SERINE HYDROLASE FORMULATION
#239Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
#240Peptoid Agonists of Nerve Growth Factor and Their Use as Medicaments
#241Macrocyclic inhibitors of hepatitis C virus replication
#242Peptide compositions and methods for treating patients
#243Peptide for augmenting and expression of BDNF and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including Alzheimer's disease or Parkinson's disease, comprising the same
#244Inhibitors of IAP
#245Asymmetric synthesis of peptides
#246HCV protease inhibitors and uses thereof
#247Biologically active peptides and their new uses
#248Gold (III) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents
#249ANGIOGENESIS INDUCING AGENT COMPRISING RECOMBINANT GELATIN
#250Compounds for enzyme inhibition
#251COSMETIC USE OF TYR-ARG DIPEPTIDE TO COMBAT CUTANEOUS SAGGING
#252Alkoxysilane derivatives of N-acyl amino acids, N-acyl dipeptides, and N-acyl tripeptides, and particles and stable oil-in-water formulations using the same
#253Methods for assaying enzyme activities
#254CGRP receptor antagonist
#255Agonists of neurotrophin receptors and their use as medicaments
#256Treatment devices and methods with extending elements
#257Skin treatment devices and methods with pre-stressed configurations
#258Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#259COLLAGEN PEPTIDE COMPOSITION HAVING GOOD ABILITY TO ENTER THE BLOOD AND FOOD OR BEVERAGE CONTAINING THE SAME
#260VEGFR-1/NRP-1 TARGETING PEPTIDES
#261COMPOSITIONS AND METHODS OF USE OF TARGETING PEPTIDES FOR DIAGNOSIS AND THERAPY OF HUMAN CANCER
#262Cysteine-free efficient Technetium (Tc) or Rhenium (Re) chelating peptide tags and their use
#263Inhibiting tumor cell invasion, metastasis and angiogenesis
#264ORGANIC COMPOUNDS
#265ASYMMETRIC SYNTHESIS OF PEPTIDES
#266Inhibition of gliadin peptides
#267FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS
#268Compounds and compositions as channel activating protease inhibitors
#269Oligomeric biosurfactants in dermatocosmetic compositions
#270Method for detecting human BPLP protein or a maturation product thereof
#271IAP BINDING COMPOUNDS
#272Dimeric Smac mimetics
#2732-Aminocarbonyl Substituted Piperazine or Diaza-Cyclic Compounds as Apoptosis Protein Inhibitors (Iap) Modulators
#274Biologically active C-terminal arginine-containing peptides
#275IAP BIR DOMAIN BINDING COMPOUNDS
#276COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS
#277Angiotensin converting enzyme inhibitory peptide
#278Fc RECEPTOR MODULATING COMPOUNDS AND COMPOSITIONS
#279FUNCTIONALIZED PYRROLIDINES AND USE THEREOF AS IAP INHIBITORS
#280Gene regulator
#281Collagen peptide conjugates and uses therefor
#282Inhibitors of mammalian tight junction opening
#283INHIBITORS OF IAP
#284ENZYMATIC CONJUGATION OF BIOACTIVE MOIETIES
#285Stabilized liquid enzyme compositions
#286BOROPEPTIDE INHIBITORS OF ENTEROPEPTIDASE AND THEIR USES IN TREATMENT OF OBESITY, OVERWEIGHT AND/OR DISEASES ASSOCIATED WITH AN ABNORMAL FAT METABOLISM
#287Mass tags for quantitative analyses
#288NOVEL PEPTIDES, USE THEREOF IN COSMETIC AND COSMECEUTIC APPLICATIONS, AND COMPOSITIONS COMPRISING SAME
#289Treatment of burns
#290Tertiary amine substituted peptides useful as inhibitors of HCV replication
#291METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION
#292Peptide production and purification process
#293Lipid tripeptide-based hydrogelator and hydrogel
#294Nucleic acid binding compounds and methods of use
#295Conformationally constrained peptide mimetics
#296Inhibitors of IAP
#297Templates for nucleation and propagation of peptide secondary structure
#298PEPTIDES AND PEPTIDE MIMETICS TO TREAT CANCER
#299IAP BIR DOMAIN BINDING COMPOUNDS
#300Tetrapeptide analogs